company background image
PMC logo

Pharmedic Pharmaceutical Medicinal HNX:PMC Stock Report

Last Price


Market Cap







23 Jun, 2024


Company Financials

Pharmedic Pharmaceutical Medicinal Joint Stock Company

HNX:PMC Stock Report

Market Cap: ₫821.3b

PMC Stock Overview

Engages in the production and distribution of pharmaceutical products for the Vietnamese community.

PMC fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance5/6
Financial Health6/6

Pharmedic Pharmaceutical Medicinal Joint Stock Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pharmedic Pharmaceutical Medicinal
Historical stock prices
Current Share Price₫88,000.00
52 Week High₫93,000.00
52 Week Low₫63,000.00
11 Month Change1.15%
3 Month Change7.32%
1 Year Change27.35%
33 Year Change30.95%
5 Year Change40.80%
Change since IPO49.08%

Recent News & Updates

Recent updates

Shareholder Returns

PMCVN PharmaceuticalsVN Market

Return vs Industry: PMC exceeded the VN Pharmaceuticals industry which returned 8.7% over the past year.

Return vs Market: PMC exceeded the VN Market which returned 11.8% over the past year.

Price Volatility

Is PMC's price volatile compared to industry and market?
PMC volatility
PMC Average Weekly Movement4.4%
Pharmaceuticals Industry Average Movement4.0%
Market Average Movement4.9%
10% most volatile stocks in VN Market7.5%
10% least volatile stocks in VN Market2.8%

Stable Share Price: PMC has not had significant price volatility in the past 3 months.

Volatility Over Time: PMC's weekly volatility (4%) has been stable over the past year.

About the Company


Pharmedic Pharmaceutical Medicinal Joint Stock Company engages in the production and distribution of pharmaceutical products for the Vietnamese community. The company offers over-the-counter medicinal products, hepatobiliary systems, cardiovascular systems, respiratory systems, central nervous systems, Musculo-skeletal systems, hormones, anti-infectives, Genito-urinary systems, endocrine and metabolic systems, and vitamins and minerals, as well as eyes, ears, nose and throat, and cough treatment products. It also provides dermatological products, allergy and immune system products, functional foods, medicines from medicinal herbs, antiseptic products, anti-allergy drugs, gastrointestinal drugs, analgesic and antipyretic products, anti-inflammatory and gout treatment products, cardiovascular and diabetes products, and neuropathy products.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Fundamentals Summary

How do Pharmedic Pharmaceutical Medicinal's earnings and revenue compare to its market cap?
PMC fundamental statistics
Market cap₫821.27b
Earnings (TTM)₫60.54b
Revenue (TTM)₫483.24b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PMC income statement (TTM)
Cost of Revenue₫314.02b
Gross Profit₫169.21b
Other Expenses₫108.67b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date


Earnings per share (EPS)6.49k
Gross Margin35.02%
Net Profit Margin12.53%
Debt/Equity Ratio0%

How did PMC perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.